News

Halma profits rise thanks to emerging markets

27 November 2008 07:24:00

Increased revenues outside its traditionally strong markets helped health and sensor group Halma post a 13% rise in interim profits as it shrugged off concerns of challenging macro-economic conditions.

Revenues increased more substantially outside the UK and USA. Progress was boosted by the contribution of Riester, particularly in Mainland Europe and South America.

The group saw double digit growth in all three business sectors. Revenues outside its traditionally strong markets of the UK, USA and Mainland Europe, now represents 21.5% of total revenue, versus 19% last year. It hopes to increase 'rest of the world' revenues to 35%.

Pre-tax profits for the six months to September rose to £35.6m from £31.4m previously on revenue that increased 19% to £221.7m, including 14% organic revenue growth.

The group said demand for its products is underpinned by long-term growth drivers and therefore it expects to continue to perform well, relative to markets as a whole.

"Our strong performance over many years confirms the resilience of Halma during challenging macro-economic conditions. In previous times of economic challenge and rapid change, Halma's ability to adapt quickly to the changing market needs has enabled us to sustain growth and frequently gain market share," said the group.

Interim dividend was raised 5% to 3.15p per share.

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.